Uncovering mechanisms of immune evasion in a novel immunogenic model of KRAS-mutant lung cancer.

被引：0
作者：
Boumelha, Jesse [1 ]
de Carne, Sophie [1 ]
Mugarza, Edurne [1 ]
Romero-Clavijo, Pablo [1 ]
Molina-Arcas, Miriam [1 ]
Downward, Julian [1 ]
机构：
[1] Francis Crick Inst, London, England
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1820
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Pang, Xiufeng
    Liu, Mingyao
    [J]. CHINESE JOURNAL OF CANCER, 2016, 35 : 92
  • [22] Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer?
    Abdel-Rahman, Omar
    [J]. JOURNAL OF THORACIC DISEASE, 2016, 8 (08) : E794 - E795
  • [23] ERK MAPK inhibition enhances the immunogenicity of KRAS-mutant colorectal cancer.
    Ryan, Meagan B.
    de la Cruz, Ferran Fece
    Ahronian, Leanne G.
    Phat, Sarah
    Myers, David T.
    Shahzade, Heather A.
    Hong, Catriona
    Corcoran, Ryan B.
    [J]. MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 76 - 76
  • [24] Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer
    Xiaoqing Luo
    Shunli Peng
    Sijie Ding
    Qin Zeng
    Rong Wang
    Yueyun Ma
    ShiYu Chen
    Yanxia Wang
    Wei Wang
    [J]. Cancer Cell International, 21
  • [25] Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer
    Luo, Xiaoqing
    Peng, Shunli
    Ding, Sijie
    Zeng, Qin
    Wang, Rong
    Ma, Yueyun
    Chen, ShiYu
    Wang, Yanxia
    Wang, Wei
    [J]. CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [26] Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer
    Li, Yunchang
    Hu, Lanlin
    Peng, Xinhao
    Xu, Huasheng
    Tang, Bo
    Xu, Chuan
    [J]. CANCER DRUG RESISTANCE, 2022, 5 (01) : 129 - 146
  • [27] Combination Immunotherapy with MEK Inhibitor for Treatment of Kras-Mutant Lung Cancer in Animal Model
    Lee, Jong Woo
    Zhang, Yu
    Choi, Justin
    Sharma, Roshan
    Park, Hee Sun
    Kaftan, Edward
    Papadimitrakopoulou, Vassiliki
    Herbst, Roy
    Koo, J. Peter
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1319 - S1319
  • [28] Impact of co-mutations on the immune microenvironment of KRAS-mutant lung adenocarcinoma
    Skoulidis, Ferdinandos
    Denning, Warren
    Diao, Lixia
    Tong, Pan
    Fan, You Hong
    Papadimitrakopoulou, Vassiliki
    Izzo, Julie
    Behrens, Carmen
    Kadara, Humam
    Cuentas, Edwin R. Parra
    Canales, Jaime Rodriguez
    Wang, Jing
    Byers, Lauren A.
    Wistuba, Ignacio I.
    Heymach, John V.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S13 - S14
  • [29] MAPK regulation of an innate immune response in KRAS-mutant lung adenocarcinoma.
    Sisler, Daniel
    Korpela, Sean
    Gurule, Natalia
    Hinz, Trista
    Marek, Lindsay
    Bullock, Bonnie
    Li, Howard
    Joshi, Molishree
    Sempeck, Colin
    Nemenoff, Raphael
    Heasley, Lynn
    [J]. MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 76 - 77
  • [30] Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
    Jeanson, Arnaud
    Tomasini, Pascale
    Souquet-Bressand, Maxime
    Brandone, Nicolas
    Boucekine, Mohamed
    Grangeon, Mathieu
    Chaleat, Solene
    Khobta, Natalyia
    Milia, Julie
    Mhanna, Laurent
    Greillier, Laurent
    Biemar, Julie
    Nanni, Isabelle
    Ouafik, L'houcine
    Garcia, Stephane
    Mazieres, Julien
    Barlesi, Fabrice
    Mascaux, Celine
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (06) : 1095 - 1101
12345